"We're improving on the OncologySTAT user experience by updating the website usability, adding mobile capability, and adding multiple specialities to appeal to more clinicians," Risko said. "PracticeUpdate is edited by experts for clinicians who want a place online to find information based on their interests."
PracticeUpdate operates independently from any particular professional society or sponsor and offers multiple marketing and promotional opportunities, including targeted advertising and sponsorship of specific site sections or content types.
Interested healthcare professionals can register for PracticeUpdate online at http://www.practiceupdate.com. For more information about marketing opportunities, please contact Denis Conlon at email@example.com.
# # #About Elsevier Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively. A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). Media contact Christopher Capot Director, Corporate Relations Elsevier +1-212-633-3164 firstname.lastname@example.org SOURCE Elsevier
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts